お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、免疫グロブリンの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に免疫グロブリン市場を分類しています。
本レポートでは世界の免疫グロブリン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Baxter、CSL、Grifols、Octapharma、Biotest、China National Pharmaceutical Group、CTBB、Hualan Bio、RAAS、Shanxi Kangbao Biological、Shuanglin Bio Pharm、Sichuan Yuanda Shuyang Pharmaceutical、Boya Bio、Jiade Bio、Weilun Bio

レポートは免疫グロブリンの主要生産者を調査し、主要地域や国の消費状況も提供します。免疫グロブリンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Intramuscular Injection Human Immunoglobulin
    Intravenous Injection Human Immunoglobulin

用途別の市場セグメント：
    Prevention of Measles
    Infectious Hepatitis
    Primary Immunoglobulin Deficiency

本レポートの詳細内容
本レポートは、世界の免疫グロブリン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて免疫グロブリン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の免疫グロブリン生産量、成長率、市場シェアを調査している。

二. 消費面では、免疫グロブリンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの免疫グロブリン売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の免疫グロブリン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本免疫グロブリンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：免疫グロブリンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 免疫グロブリンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける免疫グロブリンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章免疫グロブリンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：免疫グロブリンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：免疫グロブリンの主要メーカーの概要を提供し、製品の説明と仕様、免疫グロブリンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：免疫グロブリンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Immunoglobulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Immunoglobulin include Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group, CTBB, Hualan Bio and RAAS, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Immunoglobulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Immunoglobulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Immunoglobulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunoglobulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Immunoglobulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Immunoglobulin sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group, CTBB, Hualan Bio and RAAS, etc.

Market Segmentation
By Company
    Baxter
    CSL
    Grifols
    Octapharma
    Biotest
    China National Pharmaceutical Group
    CTBB
    Hualan Bio
    RAAS
    Shanxi Kangbao Biological
    Shuanglin Bio Pharm
    Sichuan Yuanda Shuyang Pharmaceutical
    Boya Bio
    Jiade Bio
    Weilun Bio

Segment by Type
    Intramuscular Injection Human Immunoglobulin
    Intravenous Injection Human Immunoglobulin

Segment by Application
    Prevention of Measles
    Infectious Hepatitis
    Primary Immunoglobulin Deficiency

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Immunoglobulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunoglobulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Intramuscular Injection Human Immunoglobulin
    Table 3. Major Manufacturers of Intravenous Injection Human Immunoglobulin
    Table 4. Global Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Immunoglobulin Revenue Market Share by Region (2019-2024)
    Table 9. Global Immunoglobulin Revenue Market Share by Region (2025-2030)
    Table 10. Global Immunoglobulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Immunoglobulin Sales by Region (2019-2024) & (K Pcs)
    Table 12. Global Immunoglobulin Sales by Region (2025-2030) & (K Pcs)
    Table 13. Global Immunoglobulin Sales Market Share by Region (2019-2024)
    Table 14. Global Immunoglobulin Sales Market Share by Region (2025-2030)
    Table 15. Global Immunoglobulin Sales by Manufacturers (2019-2024) & (K Pcs)
    Table 16. Global Immunoglobulin Sales Share by Manufacturers (2019-2024)
    Table 17. Global Immunoglobulin Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Immunoglobulin Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Immunoglobulin Price by Manufacturers 2019-2024 (USD/Pcs)
    Table 21. Global Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoglobulin as of 2023)
    Table 23. Global Key Manufacturers of Immunoglobulin, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Immunoglobulin, Product Offered and Application
    Table 25. Global Key Manufacturers of Immunoglobulin, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Immunoglobulin Sales by Type (2019-2024) & (K Pcs)
    Table 28. Global Immunoglobulin Sales by Type (2025-2030) & (K Pcs)
    Table 29. Global Immunoglobulin Sales Share by Type (2019-2024)
    Table 30. Global Immunoglobulin Sales Share by Type (2025-2030)
    Table 31. Global Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Immunoglobulin Revenue Share by Type (2019-2024)
    Table 34. Global Immunoglobulin Revenue Share by Type (2025-2030)
    Table 35. Immunoglobulin Price by Type (2019-2024) & (USD/Pcs)
    Table 36. Global Immunoglobulin Price Forecast by Type (2025-2030) & (USD/Pcs)
    Table 37. Global Immunoglobulin Sales by Application (2019-2024) & (K Pcs)
    Table 38. Global Immunoglobulin Sales by Application (2025-2030) & (K Pcs)
    Table 39. Global Immunoglobulin Sales Share by Application (2019-2024)
    Table 40. Global Immunoglobulin Sales Share by Application (2025-2030)
    Table 41. Global Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Immunoglobulin Revenue Share by Application (2019-2024)
    Table 44. Global Immunoglobulin Revenue Share by Application (2025-2030)
    Table 45. Immunoglobulin Price by Application (2019-2024) & (USD/Pcs)
    Table 46. Global Immunoglobulin Price Forecast by Application (2025-2030) & (USD/Pcs)
    Table 47. US & Canada Immunoglobulin Sales by Type (2019-2024) & (K Pcs)
    Table 48. US & Canada Immunoglobulin Sales by Type (2025-2030) & (K Pcs)
    Table 49. US & Canada Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Immunoglobulin Sales by Application (2019-2024) & (K Pcs)
    Table 52. US & Canada Immunoglobulin Sales by Application (2025-2030) & (K Pcs)
    Table 53. US & Canada Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Immunoglobulin Sales by Country (2019-2024) & (K Pcs)
    Table 59. US & Canada Immunoglobulin Sales by Country (2025-2030) & (K Pcs)
    Table 60. Europe Immunoglobulin Sales by Type (2019-2024) & (K Pcs)
    Table 61. Europe Immunoglobulin Sales by Type (2025-2030) & (K Pcs)
    Table 62. Europe Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Immunoglobulin Sales by Application (2019-2024) & (K Pcs)
    Table 65. Europe Immunoglobulin Sales by Application (2025-2030) & (K Pcs)
    Table 66. Europe Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Immunoglobulin Sales by Country (2019-2024) & (K Pcs)
    Table 72. Europe Immunoglobulin Sales by Country (2025-2030) & (K Pcs)
    Table 73. China Immunoglobulin Sales by Type (2019-2024) & (K Pcs)
    Table 74. China Immunoglobulin Sales by Type (2025-2030) & (K Pcs)
    Table 75. China Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Immunoglobulin Sales by Application (2019-2024) & (K Pcs)
    Table 78. China Immunoglobulin Sales by Application (2025-2030) & (K Pcs)
    Table 79. China Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Immunoglobulin Sales by Type (2019-2024) & (K Pcs)
    Table 82. Asia Immunoglobulin Sales by Type (2025-2030) & (K Pcs)
    Table 83. Asia Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Immunoglobulin Sales by Application (2019-2024) & (K Pcs)
    Table 86. Asia Immunoglobulin Sales by Application (2025-2030) & (K Pcs)
    Table 87. Asia Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Immunoglobulin Sales by Region (2019-2024) & (K Pcs)
    Table 93. Asia Immunoglobulin Sales by Region (2025-2030) & (K Pcs)
    Table 94. Middle East, Africa and Latin America Immunoglobulin Sales by Type (2019-2024) & (K Pcs)
    Table 95. Middle East, Africa and Latin America Immunoglobulin Sales by Type (2025-2030) & (K Pcs)
    Table 96. Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Immunoglobulin Sales by Application (2019-2024) & (K Pcs)
    Table 99. Middle East, Africa and Latin America Immunoglobulin Sales by Application (2025-2030) & (K Pcs)
    Table 100. Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Immunoglobulin Sales by Country (2019-2024) & (K Pcs)
    Table 106. Middle East, Africa and Latin America Immunoglobulin Sales by Country (2025-2030) & (K Pcs)
    Table 107. Baxter Company Information
    Table 108. Baxter Description and Major Businesses
    Table 109. Baxter Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 110. Baxter Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Baxter Recent Developments
    Table 112. CSL Company Information
    Table 113. CSL Description and Major Businesses
    Table 114. CSL Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 115. CSL Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. CSL Recent Developments
    Table 117. Grifols Company Information
    Table 118. Grifols Description and Major Businesses
    Table 119. Grifols Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 120. Grifols Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Grifols Recent Developments
    Table 122. Octapharma Company Information
    Table 123. Octapharma Description and Major Businesses
    Table 124. Octapharma Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 125. Octapharma Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Octapharma Recent Developments
    Table 127. Biotest Company Information
    Table 128. Biotest Description and Major Businesses
    Table 129. Biotest Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 130. Biotest Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Biotest Recent Developments
    Table 132. China National Pharmaceutical Group Company Information
    Table 133. China National Pharmaceutical Group Description and Major Businesses
    Table 134. China National Pharmaceutical Group Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 135. China National Pharmaceutical Group Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. China National Pharmaceutical Group Recent Developments
    Table 137. CTBB Company Information
    Table 138. CTBB Description and Major Businesses
    Table 139. CTBB Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 140. CTBB Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. CTBB Recent Developments
    Table 142. Hualan Bio Company Information
    Table 143. Hualan Bio Description and Major Businesses
    Table 144. Hualan Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 145. Hualan Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Hualan Bio Recent Developments
    Table 147. RAAS Company Information
    Table 148. RAAS Description and Major Businesses
    Table 149. RAAS Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 150. RAAS Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. RAAS Recent Developments
    Table 152. Shanxi Kangbao Biological Company Information
    Table 153. Shanxi Kangbao Biological Description and Major Businesses
    Table 154. Shanxi Kangbao Biological Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 155. Shanxi Kangbao Biological Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Shanxi Kangbao Biological Recent Developments
    Table 157. Shuanglin Bio Pharm Company Information
    Table 158. Shuanglin Bio Pharm Description and Major Businesses
    Table 159. Shuanglin Bio Pharm Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 160. Shuanglin Bio Pharm Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Shuanglin Bio Pharm Recent Developments
    Table 162. Sichuan Yuanda Shuyang Pharmaceutical Company Information
    Table 163. Sichuan Yuanda Shuyang Pharmaceutical Description and Major Businesses
    Table 164. Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 165. Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
    Table 167. Boya Bio Company Information
    Table 168. Boya Bio Description and Major Businesses
    Table 169. Boya Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 170. Boya Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Boya Bio Recent Developments
    Table 172. Jiade Bio Company Information
    Table 173. Jiade Bio Description and Major Businesses
    Table 174. Jiade Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 175. Jiade Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Jiade Bio Recent Developments
    Table 177. Weilun Bio Company Information
    Table 178. Weilun Bio Description and Major Businesses
    Table 179. Weilun Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 180. Weilun Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Weilun Bio Recent Developments
    Table 182. Key Raw Materials Lists
    Table 183. Raw Materials Key Suppliers Lists
    Table 184. Immunoglobulin Distributors List
    Table 185. Immunoglobulin Customers List
    Table 186. Immunoglobulin Market Trends
    Table 187. Immunoglobulin Market Drivers
    Table 188. Immunoglobulin Market Challenges
    Table 189. Immunoglobulin Market Restraints
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immunoglobulin Product Picture
    Figure 2. Global Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Immunoglobulin Market Share by Type in 2023 & 2030
    Figure 4. Intramuscular Injection Human Immunoglobulin Product Picture
    Figure 5. Intravenous Injection Human Immunoglobulin Product Picture
    Figure 6. Global Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Immunoglobulin Market Share by Application in 2023 & 2030
    Figure 8. Prevention of Measles
    Figure 9. Infectious Hepatitis
    Figure 10. Primary Immunoglobulin Deficiency
    Figure 11. Immunoglobulin Report Years Considered
    Figure 12. Global Immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Immunoglobulin Revenue 2019-2030 (US$ Million)
    Figure 14. Global Immunoglobulin Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Immunoglobulin Revenue Market Share by Region (2019-2030)
    Figure 16. Global Immunoglobulin Sales 2019-2030 ((K Pcs)
    Figure 17. Global Immunoglobulin Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Immunoglobulin Sales YoY (2019-2030) & (K Pcs)
    Figure 19. US & Canada Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Immunoglobulin Sales YoY (2019-2030) & (K Pcs)
    Figure 21. Europe Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Immunoglobulin Sales YoY (2019-2030) & (K Pcs)
    Figure 23. China Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Immunoglobulin Sales YoY (2019-2030) & (K Pcs)
    Figure 25. Asia (excluding China) Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Immunoglobulin Sales YoY (2019-2030) & (K Pcs)
    Figure 27. Middle East, Africa and Latin America Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Immunoglobulin in the World: Market Share by Immunoglobulin Revenue in 2023
    Figure 30. Global Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 32. Global Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 33. Global Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 34. Global Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Immunoglobulin Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Immunoglobulin Sales Share by Country (2019-2030)
    Figure 41. U.S. Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 44. Europe Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 46. Europe Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Immunoglobulin Revenue Share by Country (2019-2030)
    Figure 48. Europe Immunoglobulin Sales Share by Country (2019-2030)
    Figure 49. Germany Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 50. France Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 54. China Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 55. China Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 56. China Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 57. China Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 59. Asia Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 61. Asia Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Immunoglobulin Revenue Share by Region (2019-2030)
    Figure 63. Asia Immunoglobulin Sales Share by Region (2019-2030)
    Figure 64. Japan Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 68. India Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Immunoglobulin Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Immunoglobulin Sales Share by Country (2019-2030)
    Figure 75. Brazil Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 80. Immunoglobulin Value Chain
    Figure 81. Immunoglobulin Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed